Back to RHUMBLINE ADVISERS RHUMBLINE ADVISERS

ADAPYADAPY
13 quarters

Position history for RHUMBLINE ADVISERSRHUMBLINE ADVISERS's holdings in ADAPTIMMUNE THERAPEUTICS PLC Spon ADS Each Rep 6 Ord Shs

RHUMBLINE ADVISERS previously held 0 shares of ADAPY (ADAPTIMMUNE THERAPEUTICS PLC Spon ADS Each Rep 6 Ord Shs), worth $0 as of 2026-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$5,163

Total Shares Change

-5,582

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$0.02
0
2026-Q1
Unchanged
3,661
0.0%
$720.0%$0.02
0
2025-Q4
Decreased
3,661
-36.3%
$950.0%$0.03
0
2025-Q3
Decreased
5,743
-32.7%
$7450.0%$0.14
0
2025-Q2
Decreased
8,533
-53.4%
$2,0460.0%$0.25
0
2025-Q1
Decreased
18,313
-7.3%
$3,6040.0%$0.21
0
2024-Q4
Increased
19,748
+3.1%
$10,6380.0%$0.55
12
2024-Q3
Increased
19,160
+14.6%
$18,1980.0%$0.98
14
2024-Q2
Increased
16,721
+134.8%
$16,2990.0%$0.98
20
2024-Q1
Increased
7,122
+20.5%
$11,2500.0%$1.58
14
2023-Q4
Increased
5,912
+5.9%
$4,6860.0%$0.79
11
2023-Q3
Unchanged
5,582
0.0%
$4,3520.0%$0.78
0
2023-Q2
New
5,582
-
$5,1630.0%$0.94
23

Other major holders of ADAPY: RA CAPITAL MANAGEMENT, L.P., Avoro Capital Advisors LLC, Capital World Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used